Literature DB >> 28689337

Osteoid osteoma of the hand and foot in children successfully treated with radiofrequency neurotomy probes.

Gokhan Kuyumcu1, Murali Sundaram2, Jean P Schils2, Hakan Ilaslan2.   

Abstract

Osteoid osteoma is a common benign tumor that is typically found in young adults and children, usually in the long bones of the lower extremity. Radiofrequency ablation (RFA) under computed tomography guidance is the standard of care for symptomatic osteoid osteomas. However, patients with osteoid osteoma of the hand or foot are often treated with open surgery because of the risk of injury to vascular and neural structures from RFA. This risk is more pronounced in pediatric patients because of the small lesion size and proximity of lesions to important neurovascular structures. Here, we present 2 pediatric patients, one with an osteoid osteoma in the hand and the other with an osteoid osteoma in the foot. In both patients, a 22-gauge, 2.5-mm active tip ablation probe was used. The smaller ablation volume achieved with this probe protected neighboring neurovascular structures while effectively ablating the osteoid osteoma nidus. Based on our success in these cases, we recommend the application of this method for cases in which neurovascular proximity to the osteoid osteoma lesion makes ablation challenging.

Entities:  

Keywords:  Ablation; Foot; Hand; Osteoid osteoma; Pediatric; Radiofrequency; Spinal neurotomy

Mesh:

Year:  2017        PMID: 28689337     DOI: 10.1007/s00256-017-2702-x

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  25 in total

1.  Rapid development of severe osteoarthritis associated with osteoid osteoma in a young girl.

Authors:  I Foeldvari; M C Schmitz
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

Review 2.  Pediatric image-guided nonvascular musculoskeletal interventions.

Authors:  Jack-Nghia Vo; Fredric A Hoffer; Dennis W W Shaw
Journal:  Tech Vasc Interv Radiol       Date:  2010-12

Review 3.  Hand tumors: II. Benign and malignant bone tumors of the hand.

Authors:  Megan Henderson; Michael W Neumeister; Reuben A Bueno
Journal:  Plast Reconstr Surg       Date:  2014-06       Impact factor: 4.730

4.  Osteoid osteoma of the phalanx and metacarpal bone: report of 17 cases.

Authors:  M F Hamdi; L Tarhouni; M Daghfous; N Bergaoui; S Baccari
Journal:  Musculoskelet Surg       Date:  2014-08-18

5.  Prospective pilot study of CT-guided microwave ablation in the treatment of osteoid osteomas.

Authors:  Clara Prud'homme; Jean-Philippe Nueffer; Michel Runge; Jonathan Dubut; Bruno Kastler; Sébastien Aubry
Journal:  Skeletal Radiol       Date:  2016-12-27       Impact factor: 2.199

6.  Imaging features of foot osteoid osteoma.

Authors:  Satyen Shukla; Andrew W Clarke; Asif Saifuddin
Journal:  Skeletal Radiol       Date:  2009-07-15       Impact factor: 2.199

Review 7.  Percutaneous radiofrequency treatment of osteoid osteoma.

Authors:  Martin Torriani; Daniel I Rosenthal
Journal:  Pediatr Radiol       Date:  2002-06-21

8.  Percutaneous radiofrequency coagulation of osteoid osteoma compared with operative treatment.

Authors:  D I Rosenthal; F J Hornicek; M W Wolfe; L C Jennings; M C Gebhardt; H J Mankin
Journal:  J Bone Joint Surg Am       Date:  1998-06       Impact factor: 5.284

9.  [Osteoid osteoma on distal phalanx tip of second toe, without scintigraphy fixation].

Authors:  M Feron; A Desdoits; C Bronfen; C Jeanne-Pasquier; T Haumont
Journal:  Arch Pediatr       Date:  2015-11-06       Impact factor: 1.180

10.  Recurrence of an intra-articular osteoid osteoma of the great toe: a case report and review of the literature.

Authors:  Josep Torrent; Alberto Bailez; Jordi Asuncion
Journal:  J Surg Case Rep       Date:  2017-01-06
View more
  1 in total

1.  Successful percutaneous treatment of osteoid osteoma in a 13 month-old boy with radiofrequency ablation under CT guidance.

Authors:  Cennet Sahin; Yunus Oc; Naim Ediz; Aylin Hasanefendioglu Bayrak
Journal:  Acta Orthop Traumatol Turc       Date:  2018-11-13       Impact factor: 1.511

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.